<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="jah39765" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id><journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id><journal-id journal-id-type="pmc-domain-id">1888</journal-id><journal-id journal-id-type="pmc-domain">jaha</journal-id><journal-id journal-id-type="publisher-id">JAH3</journal-id><journal-title-group><journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title></journal-title-group><issn pub-type="epub">2047-9980</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11255712</article-id><article-id pub-id-type="pmcid-ver">PMC11255712.1</article-id><article-id pub-id-type="pmcaid">11255712</article-id><article-id pub-id-type="pmcaiid">11255712</article-id><article-id pub-id-type="pmid">38934855</article-id><article-id pub-id-type="doi">10.1161/JAHA.123.032787</article-id><article-id pub-id-type="publisher-id">JAH39765</article-id><article-id pub-id-type="other">JAHA/2023/032787</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject><subj-group subj-group-type="heading"><subject>Preventive Cardiology</subject></subj-group></subj-group></article-categories><title-group><article-title>Association of Cannabis Use Disorder With Hospitalizations for Pulmonary Embolism and Subsequent in&#8208;Hospital Mortality in Young Adults: A Contemporary Nationwide Analysis</article-title><alt-title alt-title-type="right-running-head">Cannabis, Pulmonary Embolism, and Mortality</alt-title><alt-title alt-title-type="left-running-head">Desai et&#160;al</alt-title></title-group><contrib-group><contrib id="jah39765-cr-0001" contrib-type="author"><name name-style="western"><surname>Desai</surname><given-names initials="R">Rupak</given-names></name><degrees>MBBS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5315-6426</contrib-id><xref rid="jah39765-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="jah39765-note-0002" ref-type="author-notes">
<sup>[Link]</sup>
</xref></contrib><contrib id="jah39765-cr-0002" contrib-type="author"><name name-style="western"><surname>Ghadge</surname><given-names initials="N">Nitin</given-names></name><degrees>MBBS, MPH</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1125-659X</contrib-id><xref rid="jah39765-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="jah39765-note-0002" ref-type="author-notes">
<sup>[Link]</sup>
</xref></contrib><contrib id="jah39765-cr-0003" contrib-type="author"><name name-style="western"><surname>Kanagala</surname><given-names initials="SG">Sai Gautham</given-names></name><degrees>MBBS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9901-0916</contrib-id><xref rid="jah39765-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jah39765-cr-0004" contrib-type="author"><name name-style="western"><surname>Katukuri</surname><given-names initials="N">Nishanth</given-names></name><degrees>MBBS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-1721-1453</contrib-id><xref rid="jah39765-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="jah39765-cr-0005" contrib-type="author"><name name-style="western"><surname>James</surname><given-names initials="A">Alpha</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0008-1181-5308</contrib-id><xref rid="jah39765-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="jah39765-cr-0006" contrib-type="author"><name name-style="western"><surname>Kadiyala</surname><given-names initials="A">Avinash</given-names></name><degrees>MBBS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0007-3970-1428</contrib-id><xref rid="jah39765-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="jah39765-cr-0007" contrib-type="author"><name name-style="western"><surname>Vutukuru</surname><given-names initials="SD">Sai Diksha</given-names></name><degrees>MBBS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0006-6898-196X</contrib-id><xref rid="jah39765-aff-0007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib id="jah39765-cr-0008" contrib-type="author"><name name-style="western"><surname>Kotharu</surname><given-names initials="M">Meghana</given-names></name><degrees>MBBS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0009-2552-0081</contrib-id><xref rid="jah39765-aff-0007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib id="jah39765-cr-0009" contrib-type="author"><name name-style="western"><surname>Borzoo</surname><given-names initials="T">Tajdin</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0000-6412-2136</contrib-id><xref rid="jah39765-aff-0008" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib id="jah39765-cr-0010" contrib-type="author"><name name-style="western"><surname>Nalla</surname><given-names initials="A">Akhila</given-names></name><degrees>MBBS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0004-6122-4574</contrib-id><xref rid="jah39765-aff-0007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib id="jah39765-cr-0011" contrib-type="author"><name name-style="western"><surname>Vyas</surname><given-names initials="A">Ankit</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1668-4120</contrib-id><xref rid="jah39765-aff-0009" ref-type="aff">
<sup>9</sup>
</xref></contrib><contrib id="jah39765-cr-0012" contrib-type="author"><name name-style="western"><surname>Priyadarshni</surname><given-names initials="S">Shivani</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6411-577X</contrib-id><xref rid="jah39765-aff-0010" ref-type="aff">
<sup>10</sup>
</xref></contrib><contrib id="jah39765-cr-0013" contrib-type="author"><name name-style="western"><surname>Shalaby</surname><given-names initials="M">Mostafa</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0008-7258-6887</contrib-id><xref rid="jah39765-aff-0010" ref-type="aff">
<sup>10</sup>
</xref></contrib><contrib id="jah39765-cr-0014" contrib-type="author" corresp="yes"><name name-style="western"><surname>Khalife</surname><given-names initials="W">Wissam</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2234-3552</contrib-id><xref rid="jah39765-aff-0010" ref-type="aff">
<sup>10</sup>
</xref><address><email>wikhalif@utmb.edu</email></address></contrib></contrib-group><aff id="jah39765-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>Independent Researcher</institution>
<city>Atlanta</city>
<named-content content-type="country-part">GA</named-content>
</aff><aff id="jah39765-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>New York State Department of Health</institution>
<city>Albany</city>
<named-content content-type="country-part">NY</named-content>
</aff><aff id="jah39765-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Metropolitan Hospital Center</institution>
<city>New York</city>
<named-content content-type="country-part">NY</named-content>
</aff><aff id="jah39765-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Internal Medicine</named-content>
<institution>Mayo Clinic</institution>
<city>Rochester</city>
<named-content content-type="country-part">MN</named-content>
</aff><aff id="jah39765-aff-0005">
<label>
<sup>5</sup>
</label>
<institution>Bukovinian State Medical University</institution>
<city>Chernivitsi</city>
<country country="UA">Ukraine</country>
</aff><aff id="jah39765-aff-0006">
<label>
<sup>6</sup>
</label>
<institution>Deccan College of Medical Sciences</institution>
<city>Hyderabad</city>
<named-content content-type="country-part">Telangana</named-content>
<country country="IN">India</country>
</aff><aff id="jah39765-aff-0007">
<label>
<sup>7</sup>
</label>
<institution>M N Raju Medical College</institution>
<city>Sangareddy</city>
<named-content content-type="country-part">Telangana</named-content>
<country country="IN">India</country>
</aff><aff id="jah39765-aff-0008">
<label>
<sup>8</sup>
</label>
<institution>Shahid Beheshti University of Medical Sciences</institution>
<city>Tehran</city>
<country country="IR">Iran</country>
</aff><aff id="jah39765-aff-0009">
<label>
<sup>9</sup>
</label>
<named-content content-type="organisation-division">Department of Vascular Medicine</named-content>
<institution>Ochsner Clinic Foundation</institution>
<city>New Orleans</city>
<named-content content-type="country-part">LA</named-content>
</aff><aff id="jah39765-aff-0010">
<label>
<sup>10</sup>
</label>
<named-content content-type="organisation-division">Department of Cardiovascular Medicine</named-content>
<institution>University of Texas Medical Branch</institution>
<city>Galveston</city>
<named-content content-type="country-part">TX</named-content>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Correspondence to: Wissam Khalife, MD, Department of Cardiovascular Medicine, The University of Texas Medical Branch, 301 University Blvd 5, 106G John Sealy Annex, Galveston, TX 77555&#8208;0553. Email: <email>wikhalif@utmb.edu</email><break/></corresp><fn id="jah39765-note-0002"><p>This manuscript was sent to Mahasin S. Mujahid, PhD, MS, Associate Editor, for review by expert referees, editorial decision, and final disposition.</p></fn></author-notes><pub-date pub-type="epub"><day>27</day><month>6</month><year>2024</year></pub-date><pub-date pub-type="collection"><day>02</day><month>7</month><year>2024</year></pub-date><volume>13</volume><issue seq="320">13</issue><issue-id pub-id-type="pmc-issue-id">466990</issue-id><issue-id pub-id-type="doi">10.1002/jah3.v13.13</issue-id><elocation-id>e032787</elocation-id><history><date date-type="received"><day>23</day><month>9</month><year>2023</year></date><date date-type="accepted"><day>01</day><month>5</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>19</day><month>07</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-07-19 00:25:26.347"><day>19</day><month>07</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2024 The Author(s). Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="JAH3-13-e032787.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:JAH3-13-e032787.pdf"/><abstract><sec id="jah39765-sec-0001"><title>Background</title><p>With the increase in popularity of cannabis and its use and the lack of large&#8208;scale data on cannabis use and venous thromboembolism and pulmonary embolism (PE), we used a nationally representative cohort of young adults (aged 18&#8211;44&#8201;years) to compare the odds of admissions and in&#8208;hospital mortality of PE with and without cannabis use disorder (CUD).</p></sec><sec id="jah39765-sec-0002"><title>Methods and Results</title><p>Identified patients with PE using the National Inpatient Sample (2018) were compared for baseline, comorbidities, and outcomes. Multivariable regression analysis, adjusted for covariates, was used to compare the odds of PE in young patients with CUD (CUD+) versus those without (CUD&#8722;) and those with prior venous thromboembolism. Propensity score&#8211;matched analysis (1:6) was also performed to assess in&#8208;hospital outcomes. A total of 61&#8201;965 (0.7%) of 8&#8201;438&#8201;858 young adult admissions in 2018 were PE related, of which 1705 (0.6%) had CUD+. On both unadjusted (odds ratio, 0.80 [95% CI, 0.71&#8211;0.90]; <italic toggle="no">P</italic>&lt;0.001) and adjusted regression analyses, the CUD+ cohort had a lower risk of PE admission. The CUD+ cohort had fewer routine discharges (58.3% versus 68.3%) and higher transfers to short&#8208;term (7.9% versus 4.8%) and nursing/intermediate care (12.6% versus 9.5%) (<italic toggle="no">P</italic>&lt;0.001). The PE&#8208;CUD+ cohort of in&#8208;hospital mortality did not differ from the CUD&#8722; cohort. Propensity score&#8211;matched (1:6) analysis revealed comparable mortality odds with higher median hospital stay and cost in the CUD+ cohort.</p></sec><sec id="jah39765-sec-0003"><title>Conclusions</title><p>Young adults with CUD demonstrated lower odds of PE hospitalizations without any association with subsequent in&#8208;hospital mortality. The median hospital stay of the CUD+ cohort was longer, they were often transferred to other facilities, and they had a higher cost.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jah39765-kwd-0001">cannabis/marijuana</kwd><kwd id="jah39765-kwd-0002">mortality</kwd><kwd id="jah39765-kwd-0003">outcomes</kwd><kwd id="jah39765-kwd-0004">pulmonary embolism</kwd><kwd id="jah39765-kwd-0005">venous thromboembolism</kwd></kwd-group><kwd-group kwd-group-type="subject-categories"><title>Subject Categories</title><kwd>Cardiovascular Disease</kwd><kwd>Lifestyle</kwd><kwd>Risk Factors</kwd></kwd-group><counts><fig-count count="1"/><table-count count="3"/><page-count count="9"/><word-count count="5100"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>02 July 2024</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.4.5 mode:remove_FC converted:06.07.2024</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="jah39765-ntgp-0001"><fn fn-type="equal" id="jah39765-note-0001"><label>*</label><p>R. Desai and N. Ghadge contributed equally.</p></fn><fn id="jah39765-note-0003"><p>For Sources of Funding and Disclosures, see page 9.</p></fn></fn-group></notes></front><body id="jah39765-body-0001"><p>
<boxed-text position="anchor" content-type="box" id="jah39765-blkfxd-0001" orientation="portrait"><caption><title>Clinical Perspective</title></caption><sec id="jah39765-sec-0006"><title>What Is New?</title><p>
<list list-type="bullet" id="jah39765-list-0001"><list-item id="jah39765-li-0001"><p>Cannabis use disorder is associated with lower risk of pulmonary embolism hospitalizations.</p></list-item><list-item id="jah39765-li-0002"><p>The cohort with cannabis use disorder had longer hospital stays, higher transfer rates, and increased cost burden.</p></list-item><list-item id="jah39765-li-0003"><p>Cannabis use disorder did not predict pulmonary embolism hospitalizations in patients with venous thromboembolism.</p></list-item></list>
</p></sec><sec id="jah39765-sec-0007"><title>What Are the Clinical Implications?</title><p>
<list list-type="bullet" id="jah39765-list-0002"><list-item id="jah39765-li-0004"><p>Cannabis use disorder was not associated with in&#8208;hospital mortality in pulmonary embolism&#8211;related admissions.</p></list-item></list>
</p></sec></boxed-text>
</p><p>In recent years, the use of cannabis (marijuana) has gained more popularity across the United States.<xref rid="jah39765-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Cannabis has the properties of an illicit drug, which could cause someone to use it more frequently than necessary, resulting in addiction. Earlier reports have suggested its potential impact on mental health and cardiovascular health outcomes.<xref rid="jah39765-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> A 2&#8208;sample Mendelian randomization study performed in 2022 examined the association between cannabis use disorder (CUD) and cardiovascular diseases.<xref rid="jah39765-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> The genetic liability of CUD was reported to be associated with a higher risk of atrial fibrillation, heart failure, pulmonary embolism (PE), and stroke.<xref rid="jah39765-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> The legalization of cannabis has drawn much attention over the past few years and has garnered much curiosity among young and older adults alike. It is estimated that 1 in 10 people who smoke marijuana will become addicted, and the risk depends on use.<xref rid="jah39765-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> There have been recent reports published on the overlapping patterns of medical and recreational marijuana. Patients who use cannabis for medical purposes are more likely to continue to use it for recreational purposes, potentially leading to an addiction.<xref rid="jah39765-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> According to the most recent National Survey on Substance Use and Health, 40.3&#8201;million people aged &#8805;12&#8201;years in the United States had experienced substance use disorders within a single year.<xref rid="jah39765-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>
</p><p>Venous thromboembolism (VTE) is an underdiagnosed and often serious but preventable medical condition. In the United States, the incidence of VTE is estimated at 117 per 100&#8201;000.<xref rid="jah39765-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Because of the prevalent occurrence of misdiagnosis or delayed detection until postmortem examination, it is conceivable that the true prevalence of these diseases exceeds the reported figures. Deep vein thrombosis and PE can happen to anyone and cause serious disabilities and sometimes fatalities. PE is the direct cause of 5% to 10% of hospital deaths.<xref rid="jah39765-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> PE is frequently encountered in elderly individuals, but it can also occur in young adults.<xref rid="jah39765-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> The presentation of PE in younger adults is typically subtle. Pregnancy and contraceptive use are routinely absent as PE risk factors. Therefore, a significantly higher level of clinical suspicion for PE is required to diagnose PE in the younger adult population. This is crucial because the mortality rate of this potentially fatal disease is low when treated with the proper medication.<xref rid="jah39765-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> The prevalence of PE increases with age, with a higher incidence in women than in men.<xref rid="jah39765-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>
</p><p>A growing body of evidence has demonstrated abnormalities in blood coagulation in association with cannabinoid use, suggesting the involvement of the endogenous cannabinoid system in modulating blood coagulation.<xref rid="jah39765-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> Despite an increase in the number of adults using cannabis both recreationally and medicinally and the number of patients experiencing PE, little is known about the association between cannabis use and VTE. We focused our efforts on CUD in this study, considering recent Canadian and American survey reports of nearly 80% endorsement and overlapping patterns of medicinal and recreational cannabis use.<xref rid="jah39765-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> The main goal of this nationwide study was to evaluate the impact of CUD on the incidence of PE&#8208;related hospitalizations in young adults, aged 18 to 44&#8201;years. We also conducted exploratory analysis to assess risk of other comorbidities and mortality among CUD cohorts. There are still significant gaps in our understanding of the relationship between CUD and PE that have important implications for public health and clinical practice and that this study aims to address.</p><sec sec-type="methods" id="jah39765-sec-0008"><title>METHODS</title><p>The data that support the findings of this study are available from the corresponding author on reasonable request.</p><p>We used the National Inpatient Sample from the Healthcare Cost and Utilization Project for the year 2018 to conduct a retrospective cohort analysis. The National Inpatient Sample is the nation's largest all&#8208;payer inpatient database, providing national estimates of hospitalizations and representing admissions from &gt;45 states. Because the National Inpatient Sample does not disclose patient&#8208;identifiable data, our study did not require Institutional Review Board approval or informed consent.</p><p>The <italic toggle="yes">International Classification of Diseases, Tenth Revision, Clinical Modification</italic> (<italic toggle="yes">ICD&#8208;10&#8208;CM</italic>), code was used to identify young individuals, aged 18 to 44&#8201;years, who presented to the hospital with acute PE as their primary or secondary diagnosis (I2601, I2602, I2609, I2690, I2692, I2693, I2694, and I2699). Patients were classified as CUD positive (+) or CUD negative (&#8722;) based on their CUD status using pertinent <italic toggle="yes">ICD&#8208;10</italic> codes, F12.1&#215; and F12.2&#215; (excluding F12.21 dependence in remission). The <italic toggle="yes">ICD&#8208;10</italic> code Z86.71&#215; was used to identify patients with history of VTE (<xref rid="jah39765-fig-0001" ref-type="fig">Figure</xref>). The primary outcome of interest was the prevalence and odds of PE&#8208;related hospitalizations in young CUD+ patients versus those without CUD. Patients with a history of VTE were also studied to assess the odds of PE in the CUD+ and CUD&#8722; cohorts.</p><fig position="float" fig-type="Figure" id="jah39765-fig-0001" orientation="portrait"><label>Figure 1</label><caption><title>Decision flowchart of eligible records identified using the National Inpatient Sample (NIS) inpatient data set with acute pulmonary embolism (PE) and cannabis use disorder.</title><p>&#160;</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="JAH3-13-e032787-g001.jpg"/></fig><p>We used descriptive statistics to characterize and compare baseline characteristics of CUD+ and CUD&#8722; cohorts and outcomes. Frequencies and percentages were used to represent categorical variables. We used &#967;<sup>2</sup> tests to compare categorical data and Mann&#8208;Whitney <italic toggle="yes">U</italic> tests to compare continuous variables because of the nonnormal distribution of the data. To compare the odds of PE in young patients with CUD+ with those without CUD, a multivariable logistic regression analysis was performed. We also modified our model to account for potential confounding factors, such as age, sex, race or ethnicity, median household income, primary expected payer, comorbidities, like hypertension, diabetes, hyperlipidemia, congestive heart failure, valvular disease, pulmonary circulation disease, peripheral vascular disease, renal failure, liver disease, metastatic cancer, solid tumor with/without metastasis, rheumatoid arthritis, coagulopathy, obesity, prior myocardial infarction, prior stroke/transient ischemic attack, sepsis, deficiency anemias, smoking, drug abuse, psychoses, and depression, and hospital bed size/location or teaching status and regions. These variables were decided from prior or current literature. Similarly, we also evaluated the prevalence in patients who had a history of VTE as a different subgroup. To assess in&#8208;hospital outcomes in PE admissions while reducing selection bias, we conducted a 1:6 propensity score&#8211;matched analysis by near neighbor match to obtain CUD+ versus CUD&#8722; cohorts, with multivariable regression for age, sex, race, household income, and hospital region, with a caliper width of 0.01. All statistical testing was done with IBM SPSS Statistics, version 25.0 (IBM Corp, Armonk, NY) on weighted data with strata/cluster designs and complex survey modules, and results with <italic toggle="yes">P</italic>&lt;0.05 were considered significant. We used the Strengthening the Reporting of Observational Studies in Epidemiology cohort checklist when writing our report.<xref rid="jah39765-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>
</p></sec><sec sec-type="results" id="jah39765-sec-0009"><title>RESULTS</title><p>Results showed that of the 8&#8201;438&#8201;858 total young adult admissions in 2018, 61&#8201;965 (0.7%) were related to acute PE. On both the unadjusted (odds ratio [OR], 0.80 [95% CI, 0.71&#8211;0.90]; <italic toggle="yes">P</italic>&lt;0.001) and adjusted (OR, 0.87 [95% CI, 0.78&#8211;0.96]; <italic toggle="yes">P</italic>=0.007) regression analyses, the odds of PE admission were lower in the CUD+ cohort compared with the CUD&#8722; cohort.</p><p>Patients in the CUD+ cohort were younger (median age, 32 versus 35&#8201;years) and more often men (56.9% versus 43.3%) compared with those in the CUD&#8722; group (<italic toggle="yes">P</italic>&lt;0.001). Black race was more associated with the CUD+ cohort than others (32.3% versus 24.5%; <italic toggle="yes">P</italic>&lt;0.001). Additionally, the CUD+ cohort had higher rates of smoking (76.0% versus 42.3%), valvular heart disease (15.5% versus 7.8%), chronic obstructive pulmonary disease (17.6% versus 15%), pulmonary circulation diseases (55.4% versus 46.8%), coagulopathy (16.4% versus 12.5%), sepsis (38.1% versus 21.6%), drug abuse (99.7% versus 18.5%), psychoses (12.9% versus 6.7%), depression (18.8% versus 14.0%), prior stroke (3.5% versus 1.9%), and liver disease (11.4% versus 7.9%), while having lower rates of diabetes (9.4% versus 6.4%), hyperlipidemia (5.6% versus 7.7%), obesity (19.9% versus 28.1%), and solid tumors without (0.9% versus 1.5%) and with metastatic cancer (2.1% versus 3.2%) (Table&#160;<xref rid="jah39765-tbl-0001" ref-type="table">1</xref>).</p><table-wrap position="float" id="jah39765-tbl-0001" content-type="Table" orientation="portrait"><label>Table 1</label><caption><p>Baseline Characteristics and Comorbidities of Young Adults Hospitalized for Acute PE With Versus Without CUD</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" colspan="1">Characteristic</th><th align="left" rowspan="1" colspan="1">No CUD</th><th align="left" rowspan="1" colspan="1">CUD</th><th align="left" rowspan="1" colspan="1">Overall acute PE admissions in young adults (aged 18&#8211;44 y)</th><th align="left" rowspan="2" colspan="1">
<italic toggle="yes">P</italic> value<xref rid="jah39765-note-0005" ref-type="table-fn">*</xref>
</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">(n=60&#8201;260)</th><th align="left" rowspan="1" colspan="1">(n=1705)</th><th align="left" rowspan="1" colspan="1">(n=61&#8201;965)</th></tr></thead><tbody><tr><td align="left" colspan="5" rowspan="1">Age at admission, median (IQR), y</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">35 (29&#8211;40)</td><td align="left" rowspan="1" colspan="1">32 (27&#8211;37)</td><td align="left" rowspan="1" colspan="1">35 (29&#8211;40)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="5" rowspan="1">Sex, %</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">43.3</td><td align="left" rowspan="1" colspan="1">56.9</td><td align="left" rowspan="1" colspan="1">43.6</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">56.7</td><td align="left" rowspan="1" colspan="1">43.1</td><td align="left" rowspan="1" colspan="1">56.4</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Race or ethnicity, %</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">White</td><td align="left" rowspan="1" colspan="1">59.3</td><td align="left" rowspan="1" colspan="1">59.3</td><td align="left" rowspan="1" colspan="1">59.3</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Black</td><td align="left" rowspan="1" colspan="1">24.5</td><td align="left" rowspan="1" colspan="1">32.3</td><td align="left" rowspan="1" colspan="1">24.7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hispanic</td><td align="left" rowspan="1" colspan="1">10.9</td><td align="left" rowspan="1" colspan="1">7.2</td><td align="left" rowspan="1" colspan="1">10.8</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Asian or Pacific Islander/Native American/others</td><td align="left" rowspan="1" colspan="1">5.3</td><td align="left" rowspan="1" colspan="1">1.2</td><td align="left" rowspan="1" colspan="1">5.2</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Median household income in the national quartile for patient zip code, %</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">0&#8211;25th</td><td align="left" rowspan="1" colspan="1">33.8</td><td align="left" rowspan="1" colspan="1">44.2</td><td align="left" rowspan="1" colspan="1">34.1</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">26th&#8211;50th</td><td align="left" rowspan="1" colspan="1">27.5</td><td align="left" rowspan="1" colspan="1">24.4</td><td align="left" rowspan="1" colspan="1">27.4</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">51st&#8211;75th</td><td align="left" rowspan="1" colspan="1">22.8</td><td align="left" rowspan="1" colspan="1">21.3</td><td align="left" rowspan="1" colspan="1">22.7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">76th&#8211;100th</td><td align="left" rowspan="1" colspan="1">16.0</td><td align="left" rowspan="1" colspan="1">10.1</td><td align="left" rowspan="1" colspan="1">15.8</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Primary expected payer, %</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Medicare</td><td align="left" rowspan="1" colspan="1">8.7</td><td align="left" rowspan="1" colspan="1">7.6</td><td align="left" rowspan="1" colspan="1">8.7</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Medicaid</td><td align="left" rowspan="1" colspan="1">38.1</td><td align="left" rowspan="1" colspan="1">55.1</td><td align="left" rowspan="1" colspan="1">38.6</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Private, including HMO</td><td align="left" rowspan="1" colspan="1">37.4</td><td align="left" rowspan="1" colspan="1">16.1</td><td align="left" rowspan="1" colspan="1">36.9</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Self&#8208;pay</td><td align="left" rowspan="1" colspan="1">10.9</td><td align="left" rowspan="1" colspan="1">17.6</td><td align="left" rowspan="1" colspan="1">11.1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No charges</td><td align="left" rowspan="1" colspan="1">1.2</td><td align="left" rowspan="1" colspan="1">1.8</td><td align="left" rowspan="1" colspan="1">1.2</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Others</td><td align="left" rowspan="1" colspan="1">3.5</td><td align="left" rowspan="1" colspan="1">1.8</td><td align="left" rowspan="1" colspan="1">3.5</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Location/teaching status of hospital, %</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rural</td><td align="left" rowspan="1" colspan="1">5.6</td><td align="left" rowspan="1" colspan="1">5.9</td><td align="left" rowspan="1" colspan="1">5.6</td><td align="left" rowspan="1" colspan="1">0.018</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Urban nonteaching</td><td align="left" rowspan="1" colspan="1">17.7</td><td align="left" rowspan="1" colspan="1">20.2</td><td align="left" rowspan="1" colspan="1">17.7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Urban teaching</td><td align="left" rowspan="1" colspan="1">76.7</td><td align="left" rowspan="1" colspan="1">73.9</td><td align="left" rowspan="1" colspan="1">76.7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Region of hospital, %</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Northeast</td><td align="left" rowspan="1" colspan="1">17.5</td><td align="left" rowspan="1" colspan="1">13.2</td><td align="left" rowspan="1" colspan="1">17.4</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Midwest</td><td align="left" rowspan="1" colspan="1">22.9</td><td align="left" rowspan="1" colspan="1">23.2</td><td align="left" rowspan="1" colspan="1">22.9</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">South</td><td align="left" rowspan="1" colspan="1">41.7</td><td align="left" rowspan="1" colspan="1">44.0</td><td align="left" rowspan="1" colspan="1">41.8</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">West</td><td align="left" rowspan="1" colspan="1">17.9</td><td align="left" rowspan="1" colspan="1">19.6</td><td align="left" rowspan="1" colspan="1">18.0</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Comorbidities, %</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hypertension</td><td align="left" rowspan="1" colspan="1">25.4</td><td align="left" rowspan="1" colspan="1">24.0</td><td align="left" rowspan="1" colspan="1">25.4</td><td align="left" rowspan="1" colspan="1">0.206</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Diabetes</td><td align="left" rowspan="1" colspan="1">11.3</td><td align="left" rowspan="1" colspan="1">9.4</td><td align="left" rowspan="1" colspan="1">11.2</td><td align="left" rowspan="1" colspan="1">0.014</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hyperlipidemia</td><td align="left" rowspan="1" colspan="1">7.7</td><td align="left" rowspan="1" colspan="1">5.6</td><td align="left" rowspan="1" colspan="1">7.7</td><td align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Obesity</td><td align="left" rowspan="1" colspan="1">28.1</td><td align="left" rowspan="1" colspan="1">19.9</td><td align="left" rowspan="1" colspan="1">27.9</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Smoking</td><td align="left" rowspan="1" colspan="1">42.3</td><td align="left" rowspan="1" colspan="1">76.0</td><td align="left" rowspan="1" colspan="1">43.2</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Congestive heart failure</td><td align="left" rowspan="1" colspan="1">8.1</td><td align="left" rowspan="1" colspan="1">8.8</td><td align="left" rowspan="1" colspan="1">8.1</td><td align="left" rowspan="1" colspan="1">0.28</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Valvular disease</td><td align="left" rowspan="1" colspan="1">7.8</td><td align="left" rowspan="1" colspan="1">15.5</td><td align="left" rowspan="1" colspan="1">8.0</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pulmonary circulation disease</td><td align="left" rowspan="1" colspan="1">46.8</td><td align="left" rowspan="1" colspan="1">55.4</td><td align="left" rowspan="1" colspan="1">47.0</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Peripheral vascular disease</td><td align="left" rowspan="1" colspan="1">6.5</td><td align="left" rowspan="1" colspan="1">11.4</td><td align="left" rowspan="1" colspan="1">6.6</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Other neurologic disorders</td><td align="left" rowspan="1" colspan="1">6.4</td><td align="left" rowspan="1" colspan="1">9.4</td><td align="left" rowspan="1" colspan="1">6.4</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Prior MI</td><td align="left" rowspan="1" colspan="1">1.3</td><td align="left" rowspan="1" colspan="1">1.8</td><td align="left" rowspan="1" colspan="1">1.3</td><td align="left" rowspan="1" colspan="1">0.103</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Prior TIA/stroke</td><td align="left" rowspan="1" colspan="1">1.9</td><td align="left" rowspan="1" colspan="1">3.5</td><td align="left" rowspan="1" colspan="1">1.9</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">History of VTE</td><td align="left" rowspan="1" colspan="1">15.3</td><td align="left" rowspan="1" colspan="1">14.7</td><td align="left" rowspan="1" colspan="1">15.3</td><td align="left" rowspan="1" colspan="1">0.476</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Chronic pulmonary disease</td><td align="left" rowspan="1" colspan="1">15.0</td><td align="left" rowspan="1" colspan="1">17.6</td><td align="left" rowspan="1" colspan="1">15.1</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Renal failure</td><td align="left" rowspan="1" colspan="1">5.6</td><td align="left" rowspan="1" colspan="1">5.9</td><td align="left" rowspan="1" colspan="1">5.6</td><td align="left" rowspan="1" colspan="1">0.577</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Liver disease</td><td align="left" rowspan="1" colspan="1">7.9</td><td align="left" rowspan="1" colspan="1">11.4</td><td align="left" rowspan="1" colspan="1">8.0</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Metastatic cancer</td><td align="left" rowspan="1" colspan="1">3.2</td><td align="left" rowspan="1" colspan="1">2.1</td><td align="left" rowspan="1" colspan="1">3.1</td><td align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Solid tumor without metastasis</td><td align="left" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">0.9</td><td align="left" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">0.032</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rheumatoid arthritis/collagen vascular diseases</td><td align="left" rowspan="1" colspan="1">3.5</td><td align="left" rowspan="1" colspan="1">2.9</td><td align="left" rowspan="1" colspan="1">3.5</td><td align="left" rowspan="1" colspan="1">0.189</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Coagulopathy</td><td align="left" rowspan="1" colspan="1">12.5</td><td align="left" rowspan="1" colspan="1">16.4</td><td align="left" rowspan="1" colspan="1">12.6</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Sepsis</td><td align="left" rowspan="1" colspan="1">21.6</td><td align="left" rowspan="1" colspan="1">38.1</td><td align="left" rowspan="1" colspan="1">22.0</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Deficiency anemias</td><td align="left" rowspan="1" colspan="1">25.7</td><td align="left" rowspan="1" colspan="1">31.7</td><td align="left" rowspan="1" colspan="1">25.8</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Drug abuse</td><td align="left" rowspan="1" colspan="1">18.5</td><td align="left" rowspan="1" colspan="1">99.7</td><td align="left" rowspan="1" colspan="1">20.8</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Psychoses</td><td align="left" rowspan="1" colspan="1">6.7</td><td align="left" rowspan="1" colspan="1">12.9</td><td align="left" rowspan="1" colspan="1">6.9</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Depression</td><td align="left" rowspan="1" colspan="1">14.0</td><td align="left" rowspan="1" colspan="1">18.8</td><td align="left" rowspan="1" colspan="1">14.2</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot id="jah39765-ntgp-0002"><fn id="jah39765-note-0004"><p>CUD indicates cannabis use disorder; HMO, health maintenance organization; IQR, interquartile range; MI, myocardial infarction; PE, pulmonary embolism; TIA, transient ischemic attack; and VTE, venous thromboembolism.</p></fn><fn id="jah39765-note-0005"><label>*</label><p>
<italic toggle="yes">P</italic>&lt;0.05 indicates statistical significance.</p></fn></table-wrap-foot></table-wrap><p>Both the univariate (3.2% versus 3.7%; <italic toggle="yes">P</italic>=0.366) and adjusted multivariable regression analyses (OR, 1.59 [95% CI, 0.82&#8211;3.09]; <italic toggle="yes">P</italic>=0.173) found no statistical difference of in&#8208;hospital mortality risk between the CUD+ cohort versus the CUD&#8722; cohort. The CUD+ cohort showed significantly lower home discharge (58.3% versus 68.3%) and a higher transfer to other facilities, like short&#8208;term facilities (7.9% versus 4.8%) and nursing/intermediate care institutions (12.6% versus 9.5%) compared with the CUD&#8722; cohort (<italic toggle="yes">P</italic>&lt;0.001) (Table&#160;<xref rid="jah39765-tbl-0002" ref-type="table">2</xref>).</p><table-wrap position="float" id="jah39765-tbl-0002" content-type="Table" orientation="portrait"><label>Table 2</label><caption><p>In&#8208;Hospital Outcomes and Multivariable Odds of PE&#8208;Related Hospitalizations and Subsequent In&#8208;Hospital Mortality in Young Patients With Versus Without CUD</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" colspan="1">Variable</th><th align="left" rowspan="1" colspan="1">No CUD</th><th align="left" rowspan="1" colspan="1">CUD</th><th align="left" rowspan="1" colspan="1">Overall acute PE admissions in young adults (aged 18&#8211;44 y)</th><th align="left" rowspan="2" colspan="1">
<italic toggle="yes">P</italic> value<xref rid="jah39765-note-0007" ref-type="table-fn">*</xref>
</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">(n=60&#8201;260)</th><th align="left" rowspan="1" colspan="1">(n=1705)</th><th align="left" rowspan="1" colspan="1">(n=61&#8201;965)</th></tr></thead><tbody><tr><td align="left" colspan="5" rowspan="1">Outcomes, %</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">In&#8208;hospital mortality</td><td align="left" rowspan="1" colspan="1">3.7</td><td align="left" rowspan="1" colspan="1">3.2</td><td align="left" rowspan="1" colspan="1">3.6</td><td align="left" rowspan="1" colspan="1">0.366</td></tr><tr><td align="left" style="padding-left:10%" colspan="5" rowspan="1">Disposition of patient</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Routine</td><td align="left" rowspan="1" colspan="1">68.3</td><td align="left" rowspan="1" colspan="1">58.5</td><td align="left" rowspan="1" colspan="1">68.1</td><td align="left" rowspan="4" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Transfers to short term facility</td><td align="left" rowspan="1" colspan="1">4.8</td><td align="left" rowspan="1" colspan="1">7.9</td><td align="left" rowspan="1" colspan="1">4.9</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Other transfers, including SNF and ICF</td><td align="left" rowspan="1" colspan="1">9.5</td><td align="left" rowspan="1" colspan="1">12.6</td><td align="left" rowspan="1" colspan="1">9.6</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Home health care</td><td align="left" rowspan="1" colspan="1">8.2</td><td align="left" rowspan="1" colspan="1">4.1</td><td align="left" rowspan="1" colspan="1">8.1</td></tr><tr><td align="left" colspan="5" rowspan="1">Length of stay, median (IQR), d</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4 (2&#8211;9)</td><td align="left" rowspan="1" colspan="1">6 (3&#8211;13)</td><td align="left" rowspan="1" colspan="1">4 (2&#8211;9)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="5" rowspan="1">Cost, median (IQR), USD</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10&#8201;458 (5583&#8211;25&#8201;249)</td><td align="left" rowspan="1" colspan="1">13&#8201;192 (6328&#8211;27&#8201;155)</td><td align="left" rowspan="1" colspan="1">10&#8201;506 (5608&#8211;25&#8201;290)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" colspan="6" rowspan="1">Association with PE&#8208;related admissions, adjusted for confounders</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" colspan="2">Acute pulmonary embolism admissions</th><th align="left" rowspan="2" colspan="1">Adjusted odds ratio&#8224;</th><th align="left" colspan="2" rowspan="1">95% CI</th><th align="left" rowspan="2" colspan="1">
<italic toggle="yes">P</italic> value</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Lower</th><th align="left" rowspan="1" colspan="1">Upper</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CUD</td><td align="left" rowspan="1" colspan="1">Yes vs no</td><td align="left" rowspan="1" colspan="1">0.87</td><td align="left" rowspan="1" colspan="1">0.78</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">0.007</td></tr></tbody></table><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" colspan="6" rowspan="1">Association with all&#8208;cause in&#8208;hospital mortality following PE admissions, adjusted for confounders</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" colspan="2">In&#8208;hospital mortality</th><th align="left" rowspan="2" colspan="1">Adjusted odds ratio<xref rid="jah39765-note-0008" ref-type="table-fn">&#8224;</xref>
</th><th align="left" colspan="2" rowspan="1">95% CI</th><th align="left" rowspan="2" colspan="1">
<italic toggle="yes">P</italic> value</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Lower</th><th align="left" rowspan="1" colspan="1">Upper</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CUD</td><td align="left" rowspan="1" colspan="1">Yes vs no</td><td align="left" rowspan="1" colspan="1">1.59</td><td align="left" rowspan="1" colspan="1">0.82</td><td align="left" rowspan="1" colspan="1">3.09</td><td align="left" rowspan="1" colspan="1">0.173</td></tr></tbody></table><table-wrap-foot id="jah39765-ntgp-0003"><fn id="jah39765-note-0006"><p>CUD indicates cannabis use disorder; ICF, intermediate&#8208;care facility; PE, pulmonary embolism; IQR, interquartile range; and SNF, skilled nursing facility.</p></fn><fn id="jah39765-note-0007"><label>*</label><p>
<italic toggle="yes">P</italic>&lt;0.05 indicates statistical significance.</p></fn><fn id="jah39765-note-0008"><label>&#8224;</label><p>Multivariable regression analyses were adjusted for the following: age (years) at admission, sex, primary expected payer, race, median household income national quartile for patient zip code, elective vs nonelective admission, bed size, location/teaching status and region of hospital, comorbidities, including hypertension, diabetes, hyperlipidemia, smoking, obesity, peripheral vascular disease, congestive heart failure, valvular disease, prior myocardial infarction, prior transient ischemic attack/stroke, history of venous thromboembolism, personal history of cancer, pulmonary circulation disease, renal failure, liver disease, other neurologic disorders, chronic pulmonary disease, hypothyroidism, AIDS, lymphoma, metastatic cancer, solid tumor without metastasis, rheumatoid arthritis/collagen vascular diseases, coagulopathy, fluid and electrolyte disorders, chronic blood loss anemia, deficiency anemias, alcohol abuse, drug abuse, depression, and sepsis.</p></fn></table-wrap-foot></table-wrap><p>On the propensity&#8208;matched (1:6) analysis of the young inpatient PE cohort, comparing patients with CUD+ against those without CUD&#8722;, both groups presented with a median age of 32&#8201;years, with comparable sex and race distribution. A significant difference was identified in socioeconomic status, as evidenced by a higher proportion of CUD+ patients in the lowest income quartile. For comorbidities, the CUD+ group exhibited significantly higher rates of smoking, alcohol abuse, coagulopathy, along with a greater prevalence of prior transient ischemic attack/stroke, valvular disease, peripheral vascular disease, chronic pulmonary disease, and deficiency anemias, compared to with CUD&#8722; counterparts; however, the prevalence of hypertension and diabetes was comparable between cohorts.</p><p>Although the all&#8208;cause mortality rates were similar between the 2 groups (3.4% for CUD+ versus 3.9% for CUD&#8722;, with an adjusted OR of 0.96 [95% CI, 0.40&#8211;2.29]; <italic toggle="yes">P</italic>=0.928), CUD+ patients faced longer hospital stays (median, 6&#8201;versus 4&#8201;days) and higher health care costs (median USD, 12 758 versus 10 033) (Table&#160;<xref rid="jah39765-tbl-0003" ref-type="table">3</xref>).</p><table-wrap position="float" id="jah39765-tbl-0003" content-type="Table" orientation="portrait"><label>Table 3</label><caption><p>Postmatching (1:6) CUD+ Versus CUD&#8722; Cohorts Among Overall PE&#8208;Related Hospitalizations</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" colspan="2" rowspan="1">Variable</th><th align="left" colspan="2" rowspan="1">No CUD (n=9225) (N, %)</th><th align="left" colspan="2" rowspan="1">CUD (n=1605) (N, %)</th><th align="left" colspan="2" rowspan="1">Overall PE&#8208;related hospitalizations (n=10&#8201;830) (N, %)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic> value<xref rid="jah39765-note-0010" ref-type="table-fn">*</xref>
</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1">Age at admission, median (IQR), y</td><td align="left" colspan="2" rowspan="1">32 (27&#8211;38)</td><td align="left" colspan="2" rowspan="1">32 (27&#8211;37)</td><td align="left" colspan="2" rowspan="1">32 (27&#8211;38)</td><td align="left" rowspan="1" colspan="1">0.223</td></tr><tr><td align="left" colspan="9" rowspan="1">Sex</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Male</td><td align="left" rowspan="1" colspan="1">5210</td><td align="left" rowspan="1" colspan="1">56.5</td><td align="left" rowspan="1" colspan="1">920</td><td align="left" rowspan="1" colspan="1">57.3</td><td align="left" rowspan="1" colspan="1">6130</td><td align="left" rowspan="1" colspan="1">56.6</td><td align="left" rowspan="2" colspan="1">0.529</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Female</td><td align="left" rowspan="1" colspan="1">4015</td><td align="left" rowspan="1" colspan="1">43.5</td><td align="left" rowspan="1" colspan="1">685</td><td align="left" rowspan="1" colspan="1">42.7</td><td align="left" rowspan="1" colspan="1">4700</td><td align="left" rowspan="1" colspan="1">43.4</td></tr><tr><td align="left" colspan="9" rowspan="1">Race or ethnicity</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">White</td><td align="left" rowspan="1" colspan="1">5560</td><td align="left" rowspan="1" colspan="1">60.3</td><td align="left" rowspan="1" colspan="1">945</td><td align="left" rowspan="1" colspan="1">58.9</td><td align="left" rowspan="1" colspan="1">6505</td><td align="left" rowspan="1" colspan="1">60.1</td><td align="left" rowspan="4" colspan="1">0.216</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Black</td><td align="left" rowspan="1" colspan="1">2930</td><td align="left" rowspan="1" colspan="1">31.8</td><td align="left" rowspan="1" colspan="1">530</td><td align="left" rowspan="1" colspan="1">33.0</td><td align="left" rowspan="1" colspan="1">3460</td><td align="left" rowspan="1" colspan="1">31.9</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Hispanic</td><td align="left" rowspan="1" colspan="1">705</td><td align="left" rowspan="1" colspan="1">7.6</td><td align="left" rowspan="1" colspan="1">120</td><td align="left" rowspan="1" colspan="1">7.5</td><td align="left" rowspan="1" colspan="1">825</td><td align="left" rowspan="1" colspan="1">7.6</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Asian or Pacific Islander/Native American/others</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">0.3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&lt;11</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" colspan="9" rowspan="1">Median household income national quartile for patient zip code region of hospital</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">0&#8211;25th</td><td align="left" rowspan="1" colspan="1">3565</td><td align="left" rowspan="1" colspan="1">38.6</td><td align="left" rowspan="1" colspan="1">710</td><td align="left" rowspan="1" colspan="1">44.2</td><td align="left" rowspan="1" colspan="1">4275</td><td align="left" rowspan="1" colspan="1">39.5</td><td align="left" rowspan="4" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">26th&#8211;50th</td><td align="left" rowspan="1" colspan="1">2485</td><td align="left" rowspan="1" colspan="1">26.9</td><td align="left" rowspan="1" colspan="1">390</td><td align="left" rowspan="1" colspan="1">24.3</td><td align="left" rowspan="1" colspan="1">2875</td><td align="left" rowspan="1" colspan="1">26.5</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">51st&#8211;75th</td><td align="left" rowspan="1" colspan="1">2305</td><td align="left" rowspan="1" colspan="1">25.0</td><td align="left" rowspan="1" colspan="1">340</td><td align="left" rowspan="1" colspan="1">21.2</td><td align="left" rowspan="1" colspan="1">2645</td><td align="left" rowspan="1" colspan="1">24.4</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">76th&#8211;100th</td><td align="left" rowspan="1" colspan="1">870</td><td align="left" rowspan="1" colspan="1">9.4</td><td align="left" rowspan="1" colspan="1">165</td><td align="left" rowspan="1" colspan="1">10.3</td><td align="left" rowspan="1" colspan="1">1035</td><td align="left" rowspan="1" colspan="1">9.6</td></tr><tr><td align="left" colspan="9" rowspan="1">Region of hospital</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Northeast</td><td align="left" rowspan="1" colspan="1">1265</td><td align="left" rowspan="1" colspan="1">13.7</td><td align="left" rowspan="1" colspan="1">205</td><td align="left" rowspan="1" colspan="1">12.8</td><td align="left" rowspan="1" colspan="1">1470</td><td align="left" rowspan="1" colspan="1">13.6</td><td align="left" rowspan="4" colspan="1">0.643</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Midwest</td><td align="left" rowspan="1" colspan="1">2180</td><td align="left" rowspan="1" colspan="1">23.6</td><td align="left" rowspan="1" colspan="1">380</td><td align="left" rowspan="1" colspan="1">23.7</td><td align="left" rowspan="1" colspan="1">2560</td><td align="left" rowspan="1" colspan="1">23.6</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">South</td><td align="left" rowspan="1" colspan="1">4010</td><td align="left" rowspan="1" colspan="1">43.5</td><td align="left" rowspan="1" colspan="1">720</td><td align="left" rowspan="1" colspan="1">44.9</td><td align="left" rowspan="1" colspan="1">4730</td><td align="left" rowspan="1" colspan="1">43.7</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">West</td><td align="left" rowspan="1" colspan="1">1770</td><td align="left" rowspan="1" colspan="1">19.2</td><td align="left" rowspan="1" colspan="1">300</td><td align="left" rowspan="1" colspan="1">18.7</td><td align="left" rowspan="1" colspan="1">2070</td><td align="left" rowspan="1" colspan="1">19.1</td></tr><tr><td align="left" colspan="9" rowspan="1">Comorbidities</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Diabetes</td><td align="left" rowspan="1" colspan="1">965</td><td align="left" rowspan="1" colspan="1">10.5</td><td align="left" rowspan="1" colspan="1">155</td><td align="left" rowspan="1" colspan="1">9.7</td><td align="left" rowspan="1" colspan="1">1120</td><td align="left" rowspan="1" colspan="1">10.3</td><td align="left" rowspan="1" colspan="1">0.329</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Hyperlipidemia</td><td align="left" rowspan="1" colspan="1">725</td><td align="left" rowspan="1" colspan="1">7.9</td><td align="left" rowspan="1" colspan="1">95</td><td align="left" rowspan="1" colspan="1">5.9</td><td align="left" rowspan="1" colspan="1">820</td><td align="left" rowspan="1" colspan="1">7.6</td><td align="left" rowspan="1" colspan="1">0.007</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Hypertension</td><td align="left" rowspan="1" colspan="1">2350</td><td align="left" rowspan="1" colspan="1">25.5</td><td align="left" rowspan="1" colspan="1">400</td><td align="left" rowspan="1" colspan="1">24.9</td><td align="left" rowspan="1" colspan="1">2750</td><td align="left" rowspan="1" colspan="1">25.4</td><td align="left" rowspan="1" colspan="1">0.639</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Smoking</td><td align="left" rowspan="1" colspan="1">3985</td><td align="left" rowspan="1" colspan="1">43.2</td><td align="left" rowspan="1" colspan="1">1225</td><td align="left" rowspan="1" colspan="1">76.3</td><td align="left" rowspan="1" colspan="1">5210</td><td align="left" rowspan="1" colspan="1">48.1</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Alcohol abuse</td><td align="left" rowspan="1" colspan="1">385</td><td align="left" rowspan="1" colspan="1">4.2</td><td align="left" rowspan="1" colspan="1">205</td><td align="left" rowspan="1" colspan="1">12.8</td><td align="left" rowspan="1" colspan="1">590</td><td align="left" rowspan="1" colspan="1">5.4</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Prior MI</td><td align="left" rowspan="1" colspan="1">150</td><td align="left" rowspan="1" colspan="1">1.6</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">1.9</td><td align="left" rowspan="1" colspan="1">180</td><td align="left" rowspan="1" colspan="1">1.7</td><td align="left" rowspan="1" colspan="1">0.482</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Prior TIA/stroke</td><td align="left" rowspan="1" colspan="1">175</td><td align="left" rowspan="1" colspan="1">1.9</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">3.7</td><td align="left" rowspan="1" colspan="1">235</td><td align="left" rowspan="1" colspan="1">2.2</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">History of VTE</td><td align="left" rowspan="1" colspan="1">1525</td><td align="left" rowspan="1" colspan="1">16.5</td><td align="left" rowspan="1" colspan="1">220</td><td align="left" rowspan="1" colspan="1">13.7</td><td align="left" rowspan="1" colspan="1">1745</td><td align="left" rowspan="1" colspan="1">16.1</td><td align="left" rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Valvular disease</td><td align="left" rowspan="1" colspan="1">815</td><td align="left" rowspan="1" colspan="1">8.8</td><td align="left" rowspan="1" colspan="1">235</td><td align="left" rowspan="1" colspan="1">14.6</td><td align="left" rowspan="1" colspan="1">1050</td><td align="left" rowspan="1" colspan="1">9.7</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Peripheral vascular disease</td><td align="left" rowspan="1" colspan="1">650</td><td align="left" rowspan="1" colspan="1">7.0</td><td align="left" rowspan="1" colspan="1">190</td><td align="left" rowspan="1" colspan="1">11.8</td><td align="left" rowspan="1" colspan="1">840</td><td align="left" rowspan="1" colspan="1">7.8</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Chronic pulmonary disease</td><td align="left" rowspan="1" colspan="1">1355</td><td align="left" rowspan="1" colspan="1">14.7</td><td align="left" rowspan="1" colspan="1">285</td><td align="left" rowspan="1" colspan="1">17.8</td><td align="left" rowspan="1" colspan="1">1640</td><td align="left" rowspan="1" colspan="1">15.1</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Hypothyroidism</td><td align="left" rowspan="1" colspan="1">360</td><td align="left" rowspan="1" colspan="1">3.9</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">1.2</td><td align="left" rowspan="1" colspan="1">380</td><td align="left" rowspan="1" colspan="1">3.5</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Coagulopathy</td><td align="left" rowspan="1" colspan="1">1055</td><td align="left" rowspan="1" colspan="1">11.4</td><td align="left" rowspan="1" colspan="1">265</td><td align="left" rowspan="1" colspan="1">16.5</td><td align="left" rowspan="1" colspan="1">1320</td><td align="left" rowspan="1" colspan="1">12.2</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Obesity</td><td align="left" rowspan="1" colspan="1">2400</td><td align="left" rowspan="1" colspan="1">26.0</td><td align="left" rowspan="1" colspan="1">315</td><td align="left" rowspan="1" colspan="1">19.6</td><td align="left" rowspan="1" colspan="1">2715</td><td align="left" rowspan="1" colspan="1">25.1</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Deficiency anemias</td><td align="left" rowspan="1" colspan="1">2130</td><td align="left" rowspan="1" colspan="1">23.1</td><td align="left" rowspan="1" colspan="1">505</td><td align="left" rowspan="1" colspan="1">31.5</td><td align="left" rowspan="1" colspan="1">2635</td><td align="left" rowspan="1" colspan="1">24.3</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">Depression</td><td align="left" rowspan="1" colspan="1">1145</td><td align="left" rowspan="1" colspan="1">12.4</td><td align="left" rowspan="1" colspan="1">295</td><td align="left" rowspan="1" colspan="1">18.4</td><td align="left" rowspan="1" colspan="1">1440</td><td align="left" rowspan="1" colspan="1">13.3</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="9" rowspan="1">In&#8208;hospital outcomes</td></tr><tr><td align="left" rowspan="3" colspan="1">All&#8208;cause mortality</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">355</td><td align="left" rowspan="1" colspan="1">3.9</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">3.4</td><td align="left" rowspan="1" colspan="1">410</td><td align="left" rowspan="1" colspan="1">3.8</td><td align="left" rowspan="1" colspan="1">0.425</td></tr><tr><td align="left" rowspan="2" colspan="1">Multivariable odds</td><td align="left" colspan="2" rowspan="1">Adjusted OR</td><td align="left" colspan="4" rowspan="1">95% CI</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic> value</td></tr><tr><td align="left" colspan="2" rowspan="1">0.96</td><td align="left" colspan="4" rowspan="1">0.40&#8211;2.29</td><td align="left" rowspan="1" colspan="1">0.928</td></tr><tr><td align="left" rowspan="4" colspan="1">
<p>Disposition of</p>
<p>patient</p>
</td><td align="left" rowspan="1" colspan="1">Routine</td><td align="left" rowspan="1" colspan="1">6270</td><td align="left" rowspan="1" colspan="1">68.0</td><td align="left" rowspan="1" colspan="1">940</td><td align="left" rowspan="1" colspan="1">58.7</td><td align="left" rowspan="1" colspan="1">7210</td><td align="left" rowspan="1" colspan="1">66.6</td><td align="left" rowspan="4" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Transfers to short&#8208;term facility</td><td align="left" rowspan="1" colspan="1">450</td><td align="left" rowspan="1" colspan="1">4.9</td><td align="left" rowspan="1" colspan="1">130</td><td align="left" rowspan="1" colspan="1">8.1</td><td align="left" rowspan="1" colspan="1">580</td><td align="left" rowspan="1" colspan="1">5.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Other transfers, including SNF and ICF</td><td align="left" rowspan="1" colspan="1">870</td><td align="left" rowspan="1" colspan="1">9.4</td><td align="left" rowspan="1" colspan="1">200</td><td align="left" rowspan="1" colspan="1">12.5</td><td align="left" rowspan="1" colspan="1">1070</td><td align="left" rowspan="1" colspan="1">9.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Home health care</td><td align="left" rowspan="1" colspan="1">715</td><td align="left" rowspan="1" colspan="1">7.8</td><td align="left" rowspan="1" colspan="1">70</td><td align="left" rowspan="1" colspan="1">4.4</td><td align="left" rowspan="1" colspan="1">785</td><td align="left" rowspan="1" colspan="1">7.3</td></tr><tr><td align="left" colspan="2" rowspan="1">Length of stay, median (IQR), d</td><td align="left" colspan="2" rowspan="1">4 (2&#8211;10)</td><td align="left" colspan="2" rowspan="1">6 (3&#8211;12)</td><td align="left" colspan="2" rowspan="1">4 (2&#8211;10)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="2" rowspan="1">Cost, median (IQR), USD</td><td align="left" colspan="2" rowspan="1">10&#8201;033 (5495&#8211;24&#8201;209)</td><td align="left" colspan="2" rowspan="1">12&#8201;758 (6306&#8211;27&#8201;014)</td><td align="left" colspan="2" rowspan="1">10&#8201;303 (5612&#8211;24&#8201;391)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot id="jah39765-ntgp-0004"><fn id="jah39765-note-0009"><p>The 1:6 propensity score matching was performed, adjusting for age, sex, race, median household income quartile, and hospital region to obtain CUD+ vs CUD&#8722; cohorts by multivariable regression analysis. Multivariable logistic regression was adjusted for these demographic factors: age at admission, sex, race, median household income national quartile for patient zip code, region of hospital, health care access and type (elective vs nonelective admission, primary expected payer, and location/teaching status of hospital), and medical history and comorbidities (diabetes, hyperlipidemia, smoking, prior MI, prior TIA/stroke, history of VTE, valvular disease, hypertension, obesity, peripheral vascular disease, chronic pulmonary disease, hypothyroidism, coagulopathy, deficiency anemias, alcohol abuse, concomitant drug abuse, and depression). CUD indicates cannabis use disorder; ICF, intermediate&#8208;care facility; IQR, interquartile range; MI, myocardial infarction; OR, odds ratio; PE, pulmonary embolism; SNF, skilled nursing facility; TIA, transient ischemic attack; and VTE, venous thromboembolism.</p></fn><fn id="jah39765-note-0010"><label>*</label><p>
<italic toggle="yes">P</italic>&lt;0.05 considered statistically significant.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="jah39765-sec-0010"><title>DISCUSSION</title><p>Substance use disorders are prevalent in North America, and CUD particularly is on the rise.<xref rid="jah39765-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> After the legalization of cannabis for medical and recreational use in some states, it is imperative to understand the potential impact on health, particularly PE.<xref rid="jah39765-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> PE is a significant cause of death worldwide,<xref rid="jah39765-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> and despite the high prevalence of cannabis use and PE, the correlation between the 2 remains unclear. Tetrahydrocannabinoids, which is a major psychoactive component of cannabis, can modulate the coagulation cascade and could result in hypercoagulability. However, the clinical relevance of these findings has never been investigated on a large scale.<xref rid="jah39765-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> To our knowledge, our study is the first step in looking into this potential relationship and analyzing the implications for public health and clinical practice to bridge the knowledge gaps, particularly focusing on young adults with CUD.</p><p>We discovered that individuals with CUD+ were less likely to experience PE than those without CUD. It is not clear that this finding is attributable to the direct effect of cannabis on the cardiovascular system, and causing vasodilation and low blood pressure could lower the risk of PE.<xref rid="jah39765-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> This finding is surprising given the known association between tetrahydrocannabinoids and platelet aggregation.<xref rid="jah39765-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> The study by Deusch et&#160;al showed that more research is needed to find out more about how tetrahydrocannabinoids affect blood clotting. The study showed that cannabinoid 1 and cannabinoid 2 were found on the cell membranes of human platelets, which may play a role.<xref rid="jah39765-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> On the contrary, it was also observed that the CUD+ group had a greater prevalence of comorbid conditions, such as valvular disease, chronic obstructive pulmonary disease, coagulopathy, sepsis, drug abuse, and psychoses. This indicates that the CUD+ group experienced an increased burden of disorders that have the potential to cause VTE. According to a study by Vakharia et&#160;al, patients with CUD have higher risks of VTE following surgical procedures like total knee arthroplasty.<xref rid="jah39765-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> A study on the endocannabinoid system suggested strong evidence for the crosstalk between the endocannabinoid system and the coagulation system.<xref rid="jah39765-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> A study by Latif and Garg indicated that since legalization, both medical and recreational cannabis use have spiked, and many cases of myocardial infarction have been linked to cannabis use, especially in young, healthy individuals.<xref rid="jah39765-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> The study also indicated that the interaction between the endocannabinoid system and the autonomic nervous system could be linked to cardiovascular adverse events.<xref rid="jah39765-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> A systematic review of mortality attributable to cannabis use found no overall increase in mortality attributable to cannabis use but noted that the prevalence of respiratory failure had increased.<xref rid="jah39765-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> This finding also shows that there is conflicting evidence because of the complex nature of the cannabis plant and the different chemicals present in it that have not been fully studied. To date, &gt;545 substances have been found in the different parts of the cannabis plant.<xref rid="jah39765-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> The phytocannabinoids are the most common type of metabolite, and they have a huge range of structures and biological functions.<xref rid="jah39765-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> With the relaxation of governing rules and legalization, there is a need for large&#8208;scale clinical research into the therapeutic use of cannabis and its phytochemicals. There is a need for further investigation into CUD and its effect on other comorbidities and PE.</p><p>After propensity score&#8211;matched analysis for PE admissions, the all&#8208;cause mortality rates for the 2 groups of our study were comparable: 3.4% for CUD+ and 3.9% for CUD&#8722; (OR, 0.96 [95% CI, 0.40&#8211;2.29]; <italic toggle="yes">P</italic>=0.928). However, CUD+ patients had longer hospital stays and more expensive care. These findings suggest that, although all&#8208;cause mortality rates were comparable, patients with CUD experienced more resource&#8208;intensive hospitalizations compared with those without CUD. Further research is needed to explore the factors contributing to these differences in health care use and costs. Additionally, understanding the impact of CUD on health care outcomes can inform targeted interventions to improve patient care and reduce health care costs.</p><p>It is important to consider some limitations when interpreting our results. First, our retrospective and observational study designs limit establishing causality between CUD and PE. Second, our reliance on national inpatient samples, which are administrative data subject to coding errors and limited clinical, and posthospitalization follow&#8208;up information may impact our findings. Third, our study's inclusion of only hospitalized patients limits the generalizability of our results to the general population. Finally, we did not collect data on cannabis consumption duration, amount, mode, or form, which could influence PE risk. Although CUD was not associated with in&#8208;hospital mortality in young adults hospitalized with PE, long&#8208;term outcomes should be evaluated in future prospective studies.</p><p>It is likely that in the future, more states adopting legalization will continue the trend of increased recreational cannabis consumption overlapping with medical cannabis. It has become more important to study the impact of CUD on younger adults and analyze the correlation between respiratory disorders, like PE, using larger and more inclusive samples.</p></sec><sec sec-type="conclusions" id="jah39765-sec-0011"><title>CONCLUSIONS</title><p>Our study found that the odds of PE admissions were lower in young adults with CUD compared with the CUD&#8722; cohort, without any significant association with subsequent in&#8208;hospital mortality. But the current literature showing hypercoagulability in the CUD+ cohort attributable to tetrahydrocannabinoids presents contrary evidence. This finding warrants further, broader investigation to determine the relationship between CUD and PE. Given the ever&#8208;growing use of cannabis recreationally, the significant overlap between medicinal and recreational use, and the high prevalence of PE, understanding the potential impact of cannabis use on the cardiovascular and pulmonary systems is important for public health and clinical practice.</p></sec><sec id="jah39765-sec-0013"><title>Sources of Funding</title><p>None.</p></sec><sec id="jah39765-sec-0014"><title>Disclosures</title><p>None.</p></sec></body><back><ack id="jah39765-sec-0012"><title>Acknowledgments</title><p>Author contributions: Rupak Desai: conceptualization, methods, software, formal analysis, resources, data curation, writing (original draft), writing (review and editing), project administration, and supervision; Nitin Ghadge: writing (original draft), writing (review and editing), visualization, and project administration; Sai Gautham Kanagala: writing (review and editing) and visualization; Nishanth Katukuri, Alpha James, Avinash Kadiyala, Sai Diksha Vutukuru, Meghana Kotharu, Tajdin Borzoo, and Akhila Nalla: writing (original draft) and writing (review and editing); Ankit Vyas, Shivani Priyadarshni, Mostafa Shalaby, and Wissam Khalife: writing (original draft), writing (review and editing), project administration, and supervision.</p></ack><ref-list content-type="cited-references" id="jah39765-bibl-0001"><title>References</title><ref id="jah39765-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jah39765-cit-0001"><string-name name-style="western"><surname>Volkow</surname><given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Compton</surname><given-names>WM</given-names></string-name>, <string-name name-style="western"><surname>Weiss</surname><given-names>SR</given-names></string-name>. <article-title>Adverse health effects of marijuana use</article-title>. <source>N Engl J Med</source>. <year>2014</year>;<volume>371</volume>:<fpage>878</fpage>&#8211;<lpage>879</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMc1407928</pub-id><pub-id pub-id-type="pmid">25162899</pub-id></mixed-citation></ref><ref id="jah39765-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jah39765-cit-0002"><string-name name-style="western"><surname>Seffah</surname><given-names>KD</given-names></string-name>, <string-name name-style="western"><surname>Mahendar</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Namballa</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Pachchipulusu</surname><given-names>VK</given-names></string-name>, <string-name name-style="western"><surname>Paudel</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Najam</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Desai</surname><given-names>HN</given-names></string-name>, <string-name name-style="western"><surname>Illango</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hamid</surname><given-names>P</given-names></string-name>. <article-title>To weed or not to weed: a systematic review exploring the potential for cannabis use in cardiovascular disease</article-title>. <source>Mental Health Pain Management Cureus</source>. <year>2023</year>;<volume>15</volume>:<elocation-id>e40606</elocation-id>. doi: <pub-id pub-id-type="doi">10.7759/cureus.40606</pub-id><pub-id pub-id-type="pmid">37476127</pub-id><pub-id pub-id-type="pmcid">PMC10353918</pub-id></mixed-citation></ref><ref id="jah39765-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jah39765-cit-0003"><string-name name-style="western"><surname>Chen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>YL</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>XF</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>L</given-names></string-name>. <article-title>Association of cannabis use disorder with cardiovascular diseases: a two&#8208;sample Mendelian randomization study</article-title>. <source>Front Cardiovasc Med</source>. <year>2022</year>;<volume>9</volume>:<elocation-id>966707</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fcvm.2022.966707</pub-id><pub-id pub-id-type="pmid">36277767</pub-id><pub-id pub-id-type="pmcid">PMC9582269</pub-id></mixed-citation></ref><ref id="jah39765-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jah39765-cit-0004"><string-name name-style="western"><surname>Copeland</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Swift</surname><given-names>W</given-names></string-name>. <article-title>Cannabis use disorder: epidemiology and management</article-title>. <source>Int Rev Psychiatry</source>. <year>2009</year>;<volume>21</volume>:<fpage>96</fpage>&#8211;<lpage>103</lpage>. doi: <pub-id pub-id-type="doi">10.1080/09540260902782745</pub-id><pub-id pub-id-type="pmid">19367503</pub-id></mixed-citation></ref><ref id="jah39765-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jah39765-cit-0005"><string-name name-style="western"><surname>Turna</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Balodis</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Munn</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Van Ameringen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Busse</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>MacKillop</surname><given-names>J</given-names></string-name>. <article-title>Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users</article-title>. <source>Compr Psychiatry</source>. <year>2020</year>;<volume>102</volume>:<elocation-id>152188</elocation-id>. doi: <pub-id pub-id-type="doi">10.1016/j.comppsych.2020.152188</pub-id><pub-id pub-id-type="pmid">32653594</pub-id></mixed-citation></ref><ref id="jah39765-bib-0006"><label>6</label><mixed-citation publication-type="book" id="jah39765-cit-0006"><collab collab-type="authors">Substance Abuse and Mental Health Services Administration</collab>
. <source>Key Substance Use and Mental Health Indicators in the United States: Results From the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21&#8208;07&#8208;01&#8208;003, NSDUH Series H&#8208;56)</source>. <publisher-name>Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration</publisher-name>; <year>2021</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.samhsa.gov/data/" ext-link-type="uri">https://www.samhsa.gov/data/</ext-link></mixed-citation></ref><ref id="jah39765-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jah39765-cit-0007"><string-name name-style="western"><surname>Silverstein</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Heit</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Mohr</surname><given-names>DN</given-names></string-name>, <string-name name-style="western"><surname>Petterson</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>O'Fallon</surname><given-names>WM</given-names></string-name>, <string-name name-style="western"><surname>Melton</surname><given-names>LJ</given-names><suffix>III</suffix></string-name>. <article-title>Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25&#8208;year population&#8208;based study</article-title>. <source>Arch Intern Med</source>. <year>1998</year>;<volume>158</volume>:<fpage>585</fpage>&#8211;<lpage>593</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archinte.158.6.585</pub-id><pub-id pub-id-type="pmid">9521222</pub-id></mixed-citation></ref><ref id="jah39765-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jah39765-cit-0008"><string-name name-style="western"><surname>Shiraev</surname><given-names>TP</given-names></string-name>, <string-name name-style="western"><surname>Omari</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Rushworth</surname><given-names>RL</given-names></string-name>. <article-title>Trends in pulmonary embolism morbidity and mortality in Australia</article-title>. <source>Thromb Res</source>. <year>2013</year>;<volume>132</volume>:<fpage>19</fpage>&#8211;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.thromres.2013.04.032</pub-id><pub-id pub-id-type="pmid">23725850</pub-id></mixed-citation></ref><ref id="jah39765-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jah39765-cit-0009"><string-name name-style="western"><surname>Kruger</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Kruger</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Collins</surname><given-names>RL</given-names></string-name>. <article-title>Cannabis enthusiasts' knowledge of medical treatment effectiveness and increased risks from cannabis use</article-title>. <source>Am J Health Promot</source>. <year>2020</year>;<volume>34</volume>:<fpage>436</fpage>&#8211;<lpage>439</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0890117119899218</pub-id><pub-id pub-id-type="pmid">31916839</pub-id></mixed-citation></ref><ref id="jah39765-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jah39765-cit-0010"><string-name name-style="western"><surname>Cerd&#225;</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Mauro</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Hamilton</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Levy</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Santaella&#8208;Tenorio</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hasin</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wall</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Keyes</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Martins</surname><given-names>SS</given-names></string-name>. <article-title>Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016</article-title>. <source>JAMA Psychiatry</source>. <year>2020</year>;<volume>77</volume>:<fpage>165</fpage>&#8211;<lpage>171</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2019.3254</pub-id><pub-id pub-id-type="pmid">31722000</pub-id><pub-id pub-id-type="pmcid">PMC6865220</pub-id></mixed-citation></ref><ref id="jah39765-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jah39765-cit-0011"><string-name name-style="western"><surname>Hammond</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Chaney</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hendrickson</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Sharma</surname><given-names>P</given-names></string-name>. <article-title>Cannabis use among U.S. adolescents in the era of marijuana legalization: a review of changing use patterns, comorbidity, and health correlates</article-title>. <source>Int Rev Psychiatry</source>. <year>2020</year>;<volume>32</volume>:<fpage>221</fpage>&#8211;<lpage>234</lpage>. doi: <pub-id pub-id-type="doi">10.1080/09540261.2020.1713056</pub-id><pub-id pub-id-type="pmid">32026735</pub-id><pub-id pub-id-type="pmcid">PMC7588219</pub-id></mixed-citation></ref><ref id="jah39765-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jah39765-cit-0012"><string-name name-style="western"><surname>Khayat</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Lehmann</surname><given-names>C</given-names></string-name>. <article-title>The endocannabinoid system: a potential therapeutic target for coagulopathies</article-title>. <source>Metabolites</source>. <year>2022</year>;<volume>12</volume>:<fpage>541</fpage>. doi: <pub-id pub-id-type="doi">10.3390/metabo12060541</pub-id><pub-id pub-id-type="pmid">35736474</pub-id><pub-id pub-id-type="pmcid">PMC9228226</pub-id></mixed-citation></ref><ref id="jah39765-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jah39765-cit-0013"><string-name name-style="western"><surname>Vandenbroucke</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>von Elm</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Altman</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>G&#248;tzsche</surname><given-names>PC</given-names></string-name>, <string-name name-style="western"><surname>Mulrow</surname><given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Pocock</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Poole</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Schlesselman</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Egger</surname><given-names>M</given-names></string-name>; <collab collab-type="authors">STROBE Initiative</collab>
. <article-title>Strengthening the reporting of observational studies in epidemiology (Strobe): explanation and elaboration</article-title>. <source>PLoS Med</source>. <year>2007</year>;<volume>4</volume>:<elocation-id>e297</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pmed.0040297</pub-id><pub-id pub-id-type="pmid">17941715</pub-id><pub-id pub-id-type="pmcid">PMC2020496</pub-id></mixed-citation></ref><ref id="jah39765-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jah39765-cit-0014"><string-name name-style="western"><surname>Martinez Licha</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>McCurdy</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Maldonado</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>LS</given-names></string-name>. <article-title>Current management of acute pulmonary embolism</article-title>. <source>Ann Thorac Cardiovasc Surg</source>. <year>2020</year>;<volume>26</volume>:<fpage>65</fpage>&#8211;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.5761/atcs.ra.19-00158</pub-id><pub-id pub-id-type="pmid">31588070</pub-id><pub-id pub-id-type="pmcid">PMC7184035</pub-id></mixed-citation></ref><ref id="jah39765-bib-0015"><label>15</label><mixed-citation publication-type="book" id="jah39765-cit-0015"><string-name name-style="western"><surname>Bondarenko</surname><given-names>AI</given-names></string-name>. <part-title>Cannabinoids and cardiovascular system</part-title>. In: <person-group person-group-type="editor"><string-name name-style="western"><surname>Bukiya</surname><given-names>AN</given-names></string-name></person-group>, ed <source>Recent Advances in Cannabinoid Physiology and Pathology</source>. Vol <volume>1162</volume>. <publisher-name>Springer International Publishing</publisher-name>; <year>2019</year>:<fpage>63</fpage>&#8211;<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-3-030-21737-2_5</pub-id><pub-id pub-id-type="pmid">31332735</pub-id></mixed-citation></ref><ref id="jah39765-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jah39765-cit-0016"><string-name name-style="western"><surname>Stupinski</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Bible</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Asmar</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Chehab</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Douglas</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ditillo</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Gries</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Khurrum</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Joseph</surname><given-names>B</given-names></string-name>. <article-title>Impact of marijuana on venous thromboembolic events: cannabinoids cause clots in trauma patients</article-title>. <source>J Trauma Acute Care Surg</source>. <year>2020</year>;<volume>89</volume>:<fpage>125</fpage>&#8211;<lpage>131</lpage>. doi: <pub-id pub-id-type="doi">10.1097/TA.0000000000002667</pub-id><pub-id pub-id-type="pmid">32209959</pub-id></mixed-citation></ref><ref id="jah39765-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jah39765-cit-0017"><string-name name-style="western"><surname>Latif</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Garg</surname><given-names>N</given-names></string-name>. <article-title>The impact of marijuana on the cardiovascular system: a review of the most common cardiovascular events associated with marijuana use</article-title>. <source>J Clin Med</source>. <year>2020</year>;<volume>9</volume>:<elocation-id>1925</elocation-id>. doi: <pub-id pub-id-type="doi">10.3390/jcm9061925</pub-id><pub-id pub-id-type="pmid">32575540</pub-id><pub-id pub-id-type="pmcid">PMC7355963</pub-id></mixed-citation></ref><ref id="jah39765-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jah39765-cit-0018"><string-name name-style="western"><surname>Deusch</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Kress</surname><given-names>HG</given-names></string-name>, <string-name name-style="western"><surname>Kraft</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Kozek&#8208;Langenecker</surname><given-names>SA</given-names></string-name>. <article-title>The procoagulatory effects of delta&#8208;9&#8208;tetrahydrocannabinol in human platelets</article-title>. <source>Anesth Analg</source>. <year>2004</year>;<volume>99</volume>:<fpage>1127</fpage>&#8211;<lpage>1130</lpage>. doi: <pub-id pub-id-type="doi">10.1213/01.ANE.0000131505.03006.74</pub-id><pub-id pub-id-type="pmid">15385362</pub-id></mixed-citation></ref><ref id="jah39765-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jah39765-cit-0019"><string-name name-style="western"><surname>Vakharia</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Sodhi</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Anis</surname><given-names>HK</given-names></string-name>, <string-name name-style="western"><surname>Ehiorobo</surname><given-names>JO</given-names></string-name>, <string-name name-style="western"><surname>Mont</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Roche</surname><given-names>MW</given-names></string-name>. <article-title>Patients who have cannabis use disorder have higher rates of venous Thromboemboli, readmission rates, and costs following primary Total knee arthroplasty</article-title>. <source>J Arthroplast</source>. <year>2020</year>;<volume>35</volume>:<fpage>997</fpage>&#8211;<lpage>1002</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.arth.2019.11.035</pub-id><pub-id pub-id-type="pmid">31973970</pub-id></mixed-citation></ref><ref id="jah39765-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jah39765-cit-0020"><string-name name-style="western"><surname>Drummer</surname><given-names>OH</given-names></string-name>, <string-name name-style="western"><surname>Gerostamoulos</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Woodford</surname><given-names>NW</given-names></string-name>. <article-title>Cannabis as a cause of death: a review</article-title>. <source>Forensic Sci Int</source>. <year>2019</year>;<volume>298</volume>:<fpage>298</fpage>&#8211;<lpage>306</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.forsciint.2019.03.007</pub-id><pub-id pub-id-type="pmid">30925348</pub-id></mixed-citation></ref><ref id="jah39765-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jah39765-cit-0021"><string-name name-style="western"><surname>Hourfane</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mechqoq</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Bekkali</surname><given-names>AY</given-names></string-name>, <string-name name-style="western"><surname>Rocha</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>El Aouad</surname><given-names>N</given-names></string-name>. <article-title>A comprehensive review on cannabis sativa ethnobotany, phytochemistry, molecular docking and biological activities</article-title>. <source>Plan Theory</source>. <year>2023</year>;<volume>12</volume>:<fpage>1245</fpage>. doi: <pub-id pub-id-type="doi">10.3390/plants12061245</pub-id><pub-id pub-id-type="pmcid">PMC10058143</pub-id><pub-id pub-id-type="pmid">36986932</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>